BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30585592)

  • 21. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
    Gerds AT; Gotlib J; Bose P; Deininger MW; Dunbar A; Elshoury A; George TI; Gojo I; Gundabolu K; Hexner E; Hobbs G; Jain T; Jamieson C; Kuykendall AT; McMahon B; Mohan SR; Oehler V; Oh S; Pardanani A; Podoltsev N; Ranheim E; Rein L; Salit R; Snyder DS; Stein BL; Talpaz M; Thota S; Vachhani P; Wadleigh M; Walsh K; Ward DC; Bergman MA; Sundar H
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1248-1269. PubMed ID: 32886902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system.
    Tefferi A; Gilliland G
    Best Pract Res Clin Haematol; 2006; 19(3):365-85. PubMed ID: 16781478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
    Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelodysplastic/myeloproliferative neoplasms.
    Cazzola M; Malcovati L; Invernizzi R
    Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The myeloproliferative neoplasms including the eosinophilia-related myeloproliferations associated with tyrosine kinase mutations: changes and issues in classification and diagnosis criteria.
    Anastasi J
    Semin Diagn Pathol; 2011 Nov; 28(4):304-13. PubMed ID: 22195408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
    Tefferi A; Vardiman JW
    Leukemia; 2008 Jan; 22(1):14-22. PubMed ID: 17882280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The World Health Organization (WHO) classification of the myeloid neoplasms.
    Vardiman JW; Harris NL; Brunning RD
    Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification.
    Hebeda KM; Fend F
    J Hematop; 2009 Sep; 2(4):205-10. PubMed ID: 20309429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Towards better understanding of hematolymphoid malignancies--based on the WHO-2008 classification: summary].
    Tohyama K
    Rinsho Byori; 2011 May; 59(5):502-3. PubMed ID: 21706866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
    Sadigh S; Kim AS
    Clin Lab Med; 2024 Jun; 44(2):339-353. PubMed ID: 38821648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Classification of myeloid leukemias].
    Kuriyama K
    Nihon Rinsho; 2009 Oct; 67(10):1853-62. PubMed ID: 19860179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.
    Zanelli M; Smith M; Zizzo M; Carloni A; Valli R; De Marco L; Foroni M; Palicelli A; Martino G; Ascani S
    BMC Pulm Med; 2019 Nov; 19(1):216. PubMed ID: 31744552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WHO classification of myeloid neoplasms and leukemia.
    Wandt H; Haferlach T; Thiede C; Ehninger G
    Blood; 2010 Jan; 115(3):748-9; author reply 749-50. PubMed ID: 20093414
    [No Abstract]   [Full Text] [Related]  

  • 39. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
    Orazi A; Germing U
    Leukemia; 2008 Jul; 22(7):1308-19. PubMed ID: 18480833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.